SCHEMBL6000650

SCHEMBL6000650

O=C(O)CN1CCN(Cc2nc(-c3ccc(NCCc4ccc(C5CCCCC5)cc4)cc3)cs2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.40
ITGB3 P05106 4/20 0.39
ITGA2B P08514 4/20 0.39
CTSL P07711 2/20 0.39
CTSB P07858 2/20 0.39
CTSS P25774 2/20 0.39
NPC1 O15118 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
MRE11 P49959 1/20 0.38
HTT P42858 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
NAMPT P43490 1/20 0.37
TRPA1 O75762 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000571 0.90 S1PR1 (0.42) MAPK1CTSLCTSBCTSSNPC1
SCHEMBL5999100 0.86 S1PR1 (0.44) MAPK1NPC1MEN1KMT2APOLB
SCHEMBL6000920 0.85 MEN1 (0.39) MAPK1CTSLCTSBCTSSNPC1
SCHEMBL5999229 0.83 NPC1 (0.41) MAPK1NPC1MEN1KMT2APOLB
SCHEMBL6001096 0.83 CTSL (0.39) MAPK1CTSLCTSBCTSSNPC1
SCHEMBL6001067 0.83 RAB9A (0.42) MAPK1NPC1MEN1KMT2APOLB
SCHEMBL6000151 0.82 GCGR (0.41) MAPK1NPC1MEN1KMT2APOLB
SCHEMBL6000648 0.82 ITGB3 (0.42) ITGB3ITGA2BCTSLCTSBCTSS
SCHEMBL6000064 0.81 NPC1 (0.41) NPC1MEN1KMT2APOLBRAB9A
SCHEMBL6000607 0.81 MEN1 (0.44) NPC1MEN1KMT2APOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 MAPK1 531/4885ITGB3 3679/4885ITGA2B 3987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.